Akèy › Distrofi myotonik › Virginia › Richmond
Etid klinik pou Distrofi myotonik nan Richmond, VA
8 etid pou Distrofi myotonik ap chèche patisipan nan sit nan ak bò kote Richmond (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Ap rekriteFaz 3
- Virginia Commonwealth University - Biotech One, Richmond
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
Ap rekriteFaz 1/2
- Virginia Commonwealth University Medical Center- Site Number : 8400006, Richmond
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
Ap rekriteEtid obsèvasyon
- Virginia Commonwealth University, Richmond
Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
Ap rekriteEtid obsèvasyon
- Virginia Commonwealth University, Richmond
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
Ap rekriteEtid obsèvasyon
- Virginia Commonwealth University, Richmond
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Ap rekriteEtid obsèvasyon
- Virginia Commonwealth University, Richmond
Study of ATX-01 in Participants With DM1
Ap rekriteFaz 1/2
- Virginia Commonwealth University, Richmond
Long-Term Development of Muscular Dystrophy Outcome Assessments
Ap rekriteEtid obsèvasyon
- Virginia Commonwealth University, Richmond
Etid Distrofi myotonik nan lòt vil
Lòt etid nan Richmond
- Kansè nan tete26 etid
- Kansè Poumon ki pa ti selil25 etid
- Kansè pwostat19 etid
- Ensifizyans kadyak16 etid
- Kansè poumon14 etid
- Kansè kolorektal13 etid
- Maladi kadyovaskilè13 etid
- Maladi fwa steatotik12 etid
- Leksemi mieloïd egi12 etid
- Karsinòm selil skuamèz tèt ak kou12 etid
- Kansè Metastatik12 etid
- Melanom11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.